Price and value in cancer care

被引：0
作者：
Saret, Cayla J. [1 ]
Cohen, Joshua T. [1 ]
Parsons, Susan K. [2 ]
Neumann, Peter J. [1 ]
机构：
[1] Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, Boston, MA 02111 USA
[2] Tufts Med Ctr, Ctr Hlth Solut, Inst Clin Res & Hlth Policy Studies, Boston, MA USA
来源：
CANCER | 2015年 / 121卷 / 22期
关键词：
COST-EFFECTIVENESS;
D O I：
10.1002/cncr.29625
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4097 / 4098
页数：2
相关论文
共 5 条
  • [1] The price of drugs for chronic myeloid leukemia (CML) is a reflection of the unsustainable prices of cancer drugs: from the perspective of a large group of CML experts
    Abboud, Camille
    Berman, Ellin
    Cohen, Adam
    Cortes, Jorge
    DeAngelo, Daniel
    Deininger, Michael
    Devine, Steven
    Druker, Brian
    Fathi, Amir
    Jabbour, Elias
    Jagasia, Madan
    Kantarjian, Hagop
    Khoury, Jean
    Laneuville, Pierre
    Larson, Richard
    Lipton, Jeffrey
    Moore, Joseph O.
    Mughal, Tariq
    O'Brien, Susan
    Pinilla-Ibarz, Javier
    Quintas-Cardama, Alfonso
    Radich, Jerald
    Reddy, Vishnu
    Schiffer, Charles
    Shah, Neil
    Shami, Paul
    Silver, Richard T.
    Snyder, David
    Stone, Richard
    Talpaz, Moshe
    Tefferi, Ayalew
    Van Etten, Richard A.
    Wetzler, Meir
    Abruzzese, Elisabetta
    Apperley, Jane
    Breccia, Massimo
    Byrne, Jenny
    Cervantes, Francisco
    Chelysheva, Ekaterina
    Clark, R. E.
    de Lavallade, Hugues
    Dyagil, Iryna
    Gambacorti-Passerini, Carlo
    Goldman, John
    Haznedaroglu, Ibrahim
    Hjorth-Hansen, Henrik
    Holyoake, Tessa
    Huntly, Brian
    le Coutre, Philipp
    Lomaia, Elza
    [J]. BLOOD, 2013, 121 (22) : 4439 - 4442
  • [2] [Anonymous], J CLIN ONCOL
  • [3] Chhatwal J, 2015, CANCER, V121
  • [4] Updating Cost-Effectiveness - The Curious Resilience of the $50,000-per-QALY Threshold
    Neumann, Peter J.
    Cohen, Joshua T.
    Weinstein, Milton C.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (09) : 796 - 797
  • [5] Value of innovation in hematologic malignancies: a systematic review of published cost-effectiveness analyses
    Saret, Cayla J.
    Winn, Aaron N.
    Shah, Gunjan
    Parsons, Susan K.
    Lin, Pei-Jung
    Cohen, Joshua T.
    Neumann, Peter J.
    [J]. BLOOD, 2015, 125 (12) : 1866 - 1869
1